(Q45010010)

8 December 2017

title

Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism (English)

1 reference

8 December 2017

0 references

1 reference

1 reference

1 reference

Shingo Maeda

1

1 reference

8 December 2017

Tsudoi Sugiura

2

1 reference

8 December 2017

Yoshiro Saikawa

3

1 reference

8 December 2017

Tetsuro Kubota

4

1 reference

8 December 2017

Yoshihide Otani

5

1 reference

8 December 2017

Koichiro Kumai

6

1 reference

8 December 2017

Masaki Kitajima

7

1 reference

8 December 2017

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

95

1 reference

8 December 2017

issue

8

1 reference

8 December 2017

page(s)

679-684

1 reference

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Induction of thymidine phosphorylase by interferon and taxanes occurs only in human cancer cells with low thymidine phosphorylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Influence of cluster formation of acidic phospholipids on decrease in the affinity for ATP of DnaA protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

An inventory of the human ABC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03329.X

10.1111/J.1349-7006.2004.TB03329.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference